key: cord-0895394-u2cbtg28
authors: Rank, Andreas; Löhr, Phillip; Hoffmann, Reinhard; Ebigbo, Alanna; Grützner, Stefanie; Schmid, Christoph; Claus, Rainer
title: Sustained cellular immunity in adults recovered from mild COVID‐19
date: 2021-01-31
journal: Cytometry A
DOI: 10.1002/cyto.a.24309
sha: 70a8b716f4b530d6c9eb2d463382bc65db85c259
doc_id: 895394
cord_uid: u2cbtg28

Transient lymphocytopenia is frequently observed in acute phase of coronavirus disease 2019 (COVID‐19). It remains a concern whether impairment of cellular immunity may be retained after COVID‐19. Here, we demonstrate by extensive lymphocyte profiling in 44 adults after mild COVID‐19 that cellular immunity is not fundamentally altered in convalescent patients. Except for increased activated CD8+ lymphocytes, total counts of B, T, and NK cells and their subsets did not differ significantly between patients after COVID‐19 and healthy controls after a median of 27 days (range 13–45) suggesting no residual cellular immune deficiency after recovery from mild COVID‐19.

Approximately 20% of patients with coronavirus disease 2019 (COVID-19) have a severe or critical disease with respiratory or multi-organ dysfunction and a high mortality rate. A total of 80% of patients present with mild COVID-19 or non-severe pneumonia according to the World Health Organization (WHO).

While pulmonary manifestations dominate the disease phenotype in most severe cases, 1 extent and consequences of impairment of other organ systems including the cellular immunity 2 with subsequent susceptibility to secondary infections are less clear to date. Transient lymphocytopenia is a common finding in and closely related viral diseases by other Coronavirinae, such as SARS and MERS. 3, 4 In contrast, lymphocytopenia is generally rare in most other viral diseases and has been reported for only few other viruses in the early phase of infection such as the avian influenza virus H5N1, the respiratory syncytial virus, or the swine foot-and-mouth disease virus. [5] [6] [7] Prolonged impaired cellular immunity following COVID-19 has been a concern based on observations from the measle virus disease where decrease of lymphocytes leads to suppression of immune response and enhanced overall childhood infectious disease mortality. 8, 9 In this study, we investigated whether patients who have recovered from COVID-19 retain alterations of their lymphocyte subset composition accompanied by transient immune suppression rendering them susceptible to subsequent infections. We focused on adult convalescents from mild COVID-19 who constitute the vast majority of patients affected from SARS-CoV-2.

Christoph Schmid and Rainer Claus contributed equally to this study.

Between April 6 and May 15, 2020, B-, T-, and NK-lymphocyte subsets and SARS-CoV-2 antibody IgG and IgA titers (Euroimmun, Lübeck, Germany) were analyzed in the peripheral blood from 44 adults recovered from COVID-19 and 44 healthy controls. All convalescent COVID-19 patients had been tested positive for SARS-CoV-2 by local health organizations and were recruited from a call for volunteers for plasma donation. At the time of study enrollment, each patient had a negative test for SARS-CoV-2 and had not shown symptoms of COVID-19 for at least 2 weeks. A historical group of healthy controls was built retrospectively from a cohort of voluntary blood donors from 2019 (pre-COVID-19 era), balancing age and gender with the COVID-19 patient group. The study was approved by the institutional ethical committee. Signed informed consent was obtained from all participants.

F I G U R E 1 Flowcytometric gating strategy of lymphocyte types and subsets from a healthy donor included in the study. Lymphocytes were identified by using forward and side scatter; B lymphocytes were defined by the presence of CD19 and T helper and cytotoxic lymphocytes by the presence of CD4 and CD8, respectively. Lymphocyte subsets were further divided as described in materials and methods and in Table S2 2.2 | Sample processing and flow cytometric analysis To assure data quality, flow rate, laser power calibration, and event dispersion of the FC 500 flow cytometer were checked on a daily basis using Flow-Check Pro Fluorospheres (Beckman Coulter).

Autosetups with Cyto-Comp Cells (Beckman Coulter) were routinely repeated for the automated compensation matrices. Voltages and compensation settings of all single channels were tested specifically with beads for the five-color flow cytometry panel of this study.

For correct identification of lymphocyte subsets, plausibility controls with reference material from healthy donors were used repeatedly and identical samples were measured as internal standards on a regular basis.

For all lymphocyte subsets, percentages were determined, and absolute numbers were calculated. Absolute leukocyte counts were measured with Stem-Count (Stem-Kit, Beckman Coulter) using CD45-FITC. A minimum of 10,000 events per aliquot of each sample was analyzed. Lymphocytes were identified by forward and side scatter. To divide lymphocytes into different subsets, established standards and a well-described gating strategy as shown in Figure 1 were used. 10 Detailed information on lymphocyte subset specific immune phenotypes and on fluorochrome-antibody conjugates are listed in Table S2 . B lymphocytes were identified by the presence of CD19 

The observation of transient lymphocytopenia in COVID-19 patients raises the question whether impairment of cellular immune response, followed by increased susceptibility to secondary infections might constitute a concern for convalescents. In this study, no significant differ- 

Postmortem examination of patients with COVID-19

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome

Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia

Pathogenesis of avian influenza A (H5N1) viruses in ferrets

Peripheral blood lymphopenia and neutrophilia in children with severe respiratory syncytial virus disease

Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV)

Measles virus-induced suppression of immune responses

Longterm measles-induced immunomodulation increases overall childhood infectious disease mortality

Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer

Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples

Sustained cellular immunity in adults recovered from mild COVID-19